Free Trial
NYSE:SOLV

Solventum Q1 2024 Earnings Report

Solventum logo
$71.33 -0.49 (-0.68%)
Closing price 09/3/2025 03:59 PM Eastern
Extended Trading
$71.54 +0.21 (+0.29%)
As of 09/3/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum EPS Results

Actual EPS
$2.08
Consensus EPS
$1.67
Beat/Miss
Beat by +$0.41
One Year Ago EPS
N/A

Solventum Revenue Results

Actual Revenue
$2.02 billion
Expected Revenue
$1.99 billion
Beat/Miss
Beat by +$30.27 million
YoY Revenue Growth
N/A

Solventum Announcement Details

Quarter
Q1 2024
Time
Before Market Opens
Conference Call Date
Thursday, May 9, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

Solventum's Q3 2025 earnings is scheduled for Thursday, November 6, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Solventum Earnings Headlines

Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel
Wall Street Zen Upgrades Solventum (NYSE:SOLV) to Strong-Buy
See More Solventum Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solventum? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solventum and other key companies, straight to your email.

About Solventum

Solventum (NYSE:SOLV), a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

View Solventum Profile

More Earnings Resources from MarketBeat